A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2011
11/09/2011	CN101269087B Pectin-5-efudix colon cancer double-target prodrug and preparation method
11/09/2011	CN101237860B Particles having hydrophobic material therein
11/09/2011	CN101039698B Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation
11/08/2011	US8053599 Drug containing (2R)-2-propyloctanoic acid as the active ingredient
11/08/2011	US8053564 Biological effectors; S-[3-({2-(3-{[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]amino}propoxy)-1,1-bis[3-{[3-(2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)propanoyl]amino}propoxy)methyl]ethyl}amino)-3-oxopropyl]ethanethioate
11/08/2011	US8053562 Modified antibody fragments
11/08/2011	US8053520 Conjugation reactions
11/08/2011	US8053469 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions
11/08/2011	US8053467 Flavor improving agent, and food and drink containing the same
11/08/2011	US8053429 Solid oral dosage form containing an enhancer
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/08/2011	US8052998 Mixture of biodegradable polymer and cationic polymer
11/08/2011	US8052992 Lipid preparation including glycerophospholid esters with polyunsaturated fatty acid (PUFA); increased bioavailability of PUFA; use as pharmaceutical, nutraceutical e.g. neurodegenerative disorders
11/08/2011	US8052991 Unsaturated fatty acid is applied on a biologically inert matrix having a large surface area and is subsequently dried; foods, beverages
11/08/2011	US8052984 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
11/08/2011	US8052981 Mono- and disaccharide derivatives
11/08/2011	US8052978 Vaccine composition against Rhodococcus equi
11/08/2011	CA2493983C Multicomponent pharmaceutical dosage form
11/08/2011	CA2489932C Compositions with anisic acid and glycerides
11/08/2011	CA2476054C Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
11/08/2011	CA2470396C Methods for preserving ophthalmic solutions and preserved ophthalmic solutions
11/08/2011	CA2466321C Gel comprising at least a retinoid and benzoyl peroxide
11/08/2011	CA2451552C Topical application of thiazolylamides
11/08/2011	CA2442539C Method and composition for solubilising a biologically active compound with low water solubility
11/08/2011	CA2413698C Endoparasiticidal agents for voluntary oral ingestion by animals
11/08/2011	CA2399100C Purified lh
11/08/2011	CA2362204C Immunogenic complexes and methods relating thereto
11/08/2011	CA2246352C Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
11/05/2011	CA2707280A1 Stabilized synthetic brood pheromone and race-specific ratios of components for manipulating the behavior and physiology of honey bees
11/03/2011	WO2011137459A1 Dosage forms of elinogrel and methods of injectable administration thereof
11/03/2011	WO2011137418A1 Selective integrin inhibitors
11/03/2011	WO2011137354A2 Delivery proteins
11/03/2011	WO2011137228A2 Composition and method for treating eustachian tube dysfunction
11/03/2011	WO2011136691A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases
11/03/2011	WO2011136645A1 Fused cyclooctyne compounds and their use in metal-free click reactions
11/03/2011	WO2011136376A1 Enteric tablet
11/03/2011	WO2011136373A1 Enteric tablet
11/03/2011	WO2011136369A1 Cationic lipid
11/03/2011	WO2011136368A1 Cationic lipid
11/03/2011	WO2011136336A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract
11/03/2011	WO2011136288A1 Transdermally absorbable donepezil-containing preparation
11/03/2011	WO2011136283A1 Skin irritation suppressant and transdermal preparation
11/03/2011	WO2011136121A1 Aqueous composition contained in container
11/03/2011	WO2011135905A1 Lipid membrane structure
11/03/2011	WO2011135461A2 Clay compositions
11/03/2011	WO2011135308A1 Conjugated blood coagulation factor viia
11/03/2011	WO2011135307A1 Conjugated blood coagulation factor viii
11/03/2011	WO2011135294A1 Method, device and system for targetted cell lysis
11/03/2011	WO2011135222A2 Use of peptides as transporters intended for the internalization of molecules of interest into target cells
11/03/2011	WO2011135150A1 Hydrogels prepared from natural anionic polymers
11/03/2011	WO2011135141A1 Modified oligonucleotides as regulators of gene expression
11/03/2011	WO2011135138A1 Lipophilic derivatives of nucleic acids
11/03/2011	WO2011135073A1 Adhesive slow-release formulations for the local administration of curcumin
11/03/2011	WO2011135067A1 Modified binding proteins inhibiting the vegf-a receptor interaction
11/03/2011	WO2011135055A1 Indigestible polymer: starch acetate -based film coatings for colon targeting
11/03/2011	WO2011134669A1 Methods for inducing an immune response
11/03/2011	WO2011134668A1 Phospholipid drug analogs
11/03/2011	WO2011134369A1 Pharmaceutical composition for improving solubility of prasugrel and its preparation method
11/03/2011	WO2011134368A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
11/03/2011	WO2011134084A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	WO2011134060A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	WO2011134056A1 Methods and uses of tie2 binding and/or activating agents
11/03/2011	WO2011087779A3 Cell tissue gel containing collagen and hyaluronan
11/03/2011	WO2011084925A3 Biomaterials made from human hair
11/03/2011	WO2011074782A3 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
11/03/2011	WO2011061516A3 Topical foam composition
11/03/2011	WO2011056775A3 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
11/03/2011	WO2011026132A8 Methods and compositions for the inhibition of transplant rejection
11/03/2011	WO2010133975A3 Reducible polyamino disulfides as transfectants
11/03/2011	WO2010120414A3 Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
11/03/2011	WO2010118238A3 Controlled release devices and methods for delivery of nucleic acids
11/03/2011	US20110269974 Polymer Derivatives
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269943 Radiolabeled annexins
11/03/2011	US20110269851 Reducing astringency in compositions containing phenolic compounds
11/03/2011	US20110269850 Shellac enteric coatings
11/03/2011	US20110269849 Emulsions and Methods for the Preparation Thereof, and Methods for Improving Oxidative Stability of Lipids
11/03/2011	US20110269848 N-substituted monomers and polymers
11/03/2011	US20110269847 Storage-stable compositions of glycerol monoalkyl ethers
11/03/2011	US20110269794 External Preparation for Athlete's Foot Treatment
11/03/2011	US20110269789 Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
11/03/2011	US20110269723 Spill resistant formulations containing clays
11/03/2011	US20110269710 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268807 Biodegradable Microspheres and Methods of Use Thereof
11/03/2011	US20110268804 Targeting of antigen presenting cells with immunonanotherapeutics
11/03/2011	US20110268803 Lung targeting dual drug delivery system
11/03/2011	US20110268789 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268769 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same
11/03/2011	US20110268690 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/03/2011	US20110268677 Silicone Paste Compositions
11/03/2011	US20110268676 Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268658 Polymer-agent conjugates, particles, compositions, and related methods of use
11/03/2011	US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011	US20110266517 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/03/2011	CA2800818A1 Cationic lipid
11/03/2011	CA2800565A1 Anti-icam-1 single domain antibody and uses thereof

1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1712